Key result
Extreme high altitude residence linked to ~141% greater risk of DKD progression versus low altitude.
Why the study?
Whether long-term residence at high altitude influences renal outcomes in patients with diabetic kidney disease remains unclear.
Does long-term residence at high altitude accelerate DKD progression in patients with Type 2 Diabetes?
Cohort (n=387)
No
Does long-term residence at high altitude accelerate DKD progression in patients with Type 2 Diabetes?
Long-term residence at extreme high altitude (≥3500 m) is associated with accelerated progression of diabetic kidney disease in patients with type 2 diabetes.
Introduction and Objective: Diabetic kidney disease (DKD) is the primary driver of end-stage renal disease (ESRD) and a major contributor to cardiovascular risk and mortality in patients with T2D. However, whether long-term residence at high altitude influences renal outcomes in patients with DKD remains unclear. Methods: This prospective cohort study enrolled 387 patients aged 18-79 years with DKD and eGFR >30 mL/min/1.73 m2 from our hospital between 2020 and 2024. Participants were stratified by residential altitude into three groups: low (<1500 m), high (1500-3500 m), and extreme high altitude (≥3500 m). DKD progression was defined as a ≥50% decline in eGFR from baseline, a doubling of the serum creatinine, onset of ESRD, or renal death. Results: Baseline characteristics are summarized in Table 1. Over a mean follow-up of 3.0 years, 56 (14.5%) patients experienced DKD progression. Multivariable Cox regression analysis revealed a graded association with altitude: compared with participants residing at low altitude, those at high altitude had an adjusted HR of 2.06 (95% CI: 0.82-5.16; P=0.124) for DKD progression, whereas those at extreme altitude had a significantly increased risk, with an adjusted HR of 2.41 (95% CI: 1.11-5.27; P=0.027). Conclusion: Long-term exposure at extreme high altitude may be associated with accelerated DKD progression in patients with T2D. Further prospective, multicenter studies are warranted to validate these findings.
No takes yet. Share an insight, caveat, or question.
ZHANG et al. (2026) conducted a cohort in Diabetic kidney disease in Type 2 Diabetes (n=387). Extreme high altitude residence (≥3500 m) vs. Low altitude residence (<1500 m) was evaluated on DKD progression (≥50% decline in eGFR from baseline, doubling of serum creatinine, onset of ESRD, or renal death) (HR 2.41, 95% CI 1.11-5.27, p=0.027). Long-term residence at extreme high altitude (≥3500 m) significantly increased the risk of diabetic kidney disease progression compared to low altitude (HR 2.41; 95% CI 1.11-5.27; P=0.027).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: